Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Applicability of Real-Time PCR Methodology in the Neonatal Detection of Turner Syndrome

Texto completo
Autor(es):
Rocha, M. N. [1] ; Longui, C. A. ; Kochi, C. ; Correa, C. S. A. ; Faria, C. D. C. ; Richeti, F. ; Melo, M. R.
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Fac Ciencias Med Santa Casa Sao Paulo, Mol Med Lab, Dept Physiol, BR-01221020 Sao Paulo - Brazil
Número total de Afiliações: 1
Tipo de documento: Artigo Científico
Fonte: Hormone and Metabolic Research; v. 42, n. 9, p. 677-681, AUG 2010.
Citações Web of Science: 4
Resumo

Turner syndrome (TS) is the complete or partial loss of the second sex chromosome, occurring in 1: 5 000 girls. Early recognition allows appropriate therapy for short stature and puberty. Neonatal diagnosis of TS permits detection of associated malformations, minimizing sequels. Aiming to develop a molecular method for the diagnosis of TS we employed blood samples stored on filter paper. We evaluated 78 female controls, 25 TS girls with 45, X karyotype, and 32 TS patients with other karyotypes. After DNA extraction, samples were submitted to real-time PCR, using primers and probes directed to the study gene ARSE and to the control gene GAPDH. A ROC curve established the ARSE: GAPDH ratio with a cutoff value of 0.7. Low ARSE: GAPDH ratio of < 0.7 was present in 100 % of 45, X TS patients. This cutoff value presented a sensitivity of 100 % and a specificity of 100 % in detecting 45, X TS patients with a positive predictive value of 100 % and a negative predictive value of 100 %. The same cutoff value was able to identify only 56 % of TS with other karyotypes, in which we observed a mean (SD) ARSE: GAPDH ratio = 0.66 (0.2); and the interquartile range = 0.4-0.8. Determination of ARSE: GAPDH ratio is a fast, sensitive, and specific method, with viable cost and feasible automation, which makes it potentially applicable in neonatal screening programs for the diagnosis of Turner syndrome 45,X. (AU)

Processo FAPESP: 07/54224-6 - Acuracia diagnostica de um novo metodo para triagem da sindrome de turner por pcr em tempo real.
Beneficiário:Murilo Rezende Melo
Modalidade de apoio: Auxílio à Pesquisa - Regular